Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Suha Abushamma"'
Publikováno v:
BMC Health Services Research, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background & aim Smoking is a major risk factor for multiple gastrointestinal cancers, and adversely affects peptic ulcer disease, gastroesophageal reflux, pancreatitis and Crohn’s disease. Despite key recommendations for diagnosing and tr
Externí odkaz:
https://doaj.org/article/bfd8595a01c14a83a49579031ff728ab
Publikováno v:
Crohn's & Colitis 360.
Background & Aim Infliximab is typically given over an infusion time of 2 hours, leading to a significant burden in inflammatory bowel disease (IBD) patients. We aimed to determine the safety and cost-effectiveness of an accelerated infliximab infusi
Autor:
Suha Abushamma, Hisham Assem
Publikováno v:
Digestive Diseases and Sciences. 68:2209-2210
Autor:
Rebecca E Schriefer, Dana C. Perantie, Lynne M. Mitchell, Darren Nix, Alexander Carvidi, Gregory F. Wu, Suha Abushamma, Diana Paez, Lily E McMorrow, Alem Haile, Kimberly E. Taylor, Alfred H.J. Kim, Michael A. Paley, Niti Pawar, Sewuese E. Akuse, Shannon E Sides, Maté Gergely, Alia A El-Qunni, Baylee Kinnett, William Buchser, Michael K. Klebert, Matthew A. Ciorba, Salim Chahin, Wooseob Kim, Katherine Huang, Patricia P. Katz, Lianne S. Gensler, Ali H. Ellebedy, Mary C. Nakamura, Monica Yang, Mariel J. Liebeskind, Jonathan Graf, Sean P. J. Whelan, Zhuoming Liu, Mehrdad Matloubian, Mahima Thapa, Jane A. O’Halloran, Emanuel G Demissie, Parakkal Deepak, Rachel M. Presti
Publikováno v:
Annals of internal medicine, vol 174, iss 11
BackgroundPatients with chronic inflammatory disease (CID) treated with immunosuppressive medications have increased risk for severe COVID-19. Although mRNA-based SARS-CoV-2 vaccination provides protection in immunocompetent persons, immunogenicity i
Publikováno v:
Current Opinion in Gastroenterology. 37:295-305
Purpose of review Multiple new medications with novel mechanisms of action are now available to treat Crohn's disease (CD). However, they have varying effectiveness in the management of perianal CD. Identifying the most appropriate therapy and optimi
Autor:
Peiman Milani, Pablo Torres-Aguilar, Bruce Hamaker, Mark Manary, Suha Abushamma, Amos Laar, Roy Steiner, Mehrdad Ehsani, John de la Parra, Daniel Skaven-Ruben, Henriette de Kock, Corina Hawkes, Namukolo Covic, Chris Mitchell, John Taylor
Publikováno v:
Global Food Security. 34:100649
Autor:
Florian Rieder, Suha Abushamma, Ruishen Lyu, Stefan D. Holubar, Jacob A. Kurowski, Ilyssa O. Gordon, Lei Kou
Publikováno v:
J Crohns Colitis
Background and Aims Intestinal fibrosis has recently been characterised in adult ulcerative colitis and may affect motility, diarrhoea, and the symptom of urgency. We aimed to charactersze the presence of fibrosis in paediatric patients with ulcerati
Autor:
Dayna S. Early, Suha Abushamma
Publikováno v:
Obstetrics and gynecology. 137(6)
This monograph provides an overview of pathophysiology and screening, followed by sections on diagnosis and management of upper gastrointestinal, biliary, and pancreatic disorders. The most common upper gastrointestinal disorder is GERD, which affect
Autor:
Ali H. Ellebedy, Mary C. Nakamura, Alexander Carvidi, Kuan-lin Huang, Jonathan Graf, Lily E McMorrow, Suha Abushamma, Rachel M. Presti, William Buchser, Rebecca E Schriefer, Alem Haile, Matthew A. Ciorba, Mehrdad Matloubian, Mahima Thapa, Jane A. O’Halloran, Lianne S. Gensler, A. A. El-Qunni, Lynne M. Mitchell, Patricia P. Katz, D. Paez, Sean P. J. Whelan, S. E. Sides, M. Yang, Dana C. Perantie, Darren Nix, Maté Gergely, Wooseob Kim, Parakkal Deepak, Kristopher Taylor, Salim Chahin, Michael K. Klebert, Michael A. Paley, Gregory F. Wu, Mariel J. Liebeskind, Alfred H.J. Kim, Baylee Kinnett, Zhuoming Liu
Publikováno v:
medRxiv
article-version (status) pre
article-version (number) 2
article-version (status) pre
article-version (number) 2
BackgroundIndividuals with chronic inflammatory diseases (CID) are frequently treated with immunosuppressive medications that can increase their risk of severe COVID-19. While novel mRNA-based SARS-CoV-2 vaccination platforms provide robust protectio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0280e32973da1df138c20c3cb38547d9
https://doi.org/10.1101/2021.04.05.21254656
https://doi.org/10.1101/2021.04.05.21254656
Autor:
Suha, Abushamma, Parakkal, Deepak
Publikováno v:
Alimentary pharmacologytherapeuticsREFERENCES. 53(8)